Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 2
2009 3
2010 4
2011 5
2012 4
2013 8
2014 4
2015 8
2016 7
2017 3
2018 2
2019 9
2020 8
2021 2
2022 5
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Results by year

Filters applied: . Clear all
Page 1
Immunotherapeutic approaches for hepatocellular carcinoma.
Longo V, Gnoni A, Casadei Gardini A, Pisconti S, Licchetta A, Scartozzi M, Memeo R, Palmieri VO, Aprile G, Santini D, Nardulli P, Silvestris N, Brunetti O. Longo V, et al. Among authors: gnoni a. Oncotarget. 2017 May 16;8(20):33897-33910. doi: 10.18632/oncotarget.15406. Oncotarget. 2017. PMID: 28420805 Free PMC article. Review.
Target therapies in pancreatic carcinoma.
Silvestris N, Gnoni A, Brunetti AE, Vincenti L, Santini D, Tonini G, Merchionne F, Maiello E, Lorusso V, Nardulli P, Azzariti A, Reni M. Silvestris N, et al. Among authors: gnoni a. Curr Med Chem. 2014;21(8):948-65. doi: 10.2174/09298673113209990238. Curr Med Chem. 2014. PMID: 23992319 Review.
Angiogenesis in pancreatic ductal adenocarcinoma: A controversial issue.
Longo V, Brunetti O, Gnoni A, Cascinu S, Gasparini G, Lorusso V, Ribatti D, Silvestris N. Longo V, et al. Among authors: gnoni a. Oncotarget. 2016 Sep 6;7(36):58649-58658. doi: 10.18632/oncotarget.10765. Oncotarget. 2016. PMID: 27462915 Free PMC article. Review.
Emerging role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma.
Longo V, Brunetti O, Gnoni A, Licchetta A, Delcuratolo S, Memeo R, Solimando AG, Argentiero A. Longo V, et al. Among authors: gnoni a. Medicina (Kaunas). 2019 Oct 17;55(10):698. doi: 10.3390/medicina55100698. Medicina (Kaunas). 2019. PMID: 31627433 Free PMC article. Review.
Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib.
Brunetti O, Gnoni A, Licchetta A, Longo V, Calabrese A, Argentiero A, Delcuratolo S, Solimando AG, Casadei-Gardini A, Silvestris N. Brunetti O, et al. Among authors: gnoni a. Medicina (Kaunas). 2019 Oct 21;55(10):707. doi: 10.3390/medicina55100707. Medicina (Kaunas). 2019. PMID: 31640191 Free PMC article. Review.
Carcinogenesis of pancreatic adenocarcinoma: precursor lesions.
Gnoni A, Licchetta A, Scarpa A, Azzariti A, Brunetti AE, Simone G, Nardulli P, Santini D, Aieta M, Delcuratolo S, Silvestris N. Gnoni A, et al. Int J Mol Sci. 2013 Sep 30;14(10):19731-62. doi: 10.3390/ijms141019731. Int J Mol Sci. 2013. PMID: 24084722 Free PMC article. Review.
Dasatinib: an anti-tumour agent via Src inhibition.
Gnoni A, Marech I, Silvestris N, Vacca A, Lorusso V. Gnoni A, et al. Curr Drug Targets. 2011 Apr;12(4):563-78. doi: 10.2174/138945011794751591. Curr Drug Targets. 2011. PMID: 21226671 Review.
76 results